SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending as a critical player in the booming AI data center market, with its advanced GaN and SiC power solutions integral to high-efficiency architectures, including NVIDIA's 800V ecosystem. The community is actively speculating on potential contract announcements and the impact of significant short interest, creating strong buzz around the stock's growth prospects and a prospective market surge.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor Manufacturing is trending after reporting strong earnings that surpassed expectations and highlighted an accelerating artificial intelligence boom. The company's optimistic outlook, including substantial capital expenditure plans, is sparking widespread confidence across the semiconductor sector and its supply chain partners. Community discussion emphasizes TSM's role as a bellwether, reinforcing the belief in a sustained 'AI megatrend' rather than a short-term bubble.

High Roller Technologies, Inc. is an evolving and growth-oriented iCasino and entertainment company, which engages in the business of operating an online gaming business offering casino betting games to customers. The firm also offers a wide range of games including many that are available in land-based casinos, such as blackjack, roulette, baccarat, poker, and slot machines. The company was founded by Michael Alexander Cribari and Brandon Christopher Eachus on December 21, 2021 and is headquartered in Las Vegas, NV.

High Roller Technologies Inc.

High Roller Technologies Inc

High Roller Technologies (ROLR) is trending due to its strategic partnership with crypto.com/us to launch a U.S. prediction markets platform, alongside plans for sports betting expansion. This news has sparked significant community discussion, with many anticipating a continued rally and potential short squeeze, while others debate its sustainability and the possibility of an offering.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is rallying sharply amid widespread anticipation of a memory supercycle, driven by tight NAND supply and significant price increases for enterprise SSDs due to surging AI infrastructure demand. The community is fiercely debating whether this remarkable surge, which has pushed the stock to new highs, is sustainable or if it represents an overextended move poised for a correction.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending amidst intense investor frustration following a perceived lack of concrete announcements from its J.P. Morgan Healthcare Conference presentation, with the community actively discussing CEO John Jacobs' perceived inaction and vague guidance. Despite recognition of its valuable Matrix-M adjuvant platform and recent analyst optimism, shareholders are demanding tangible updates on new partnerships, especially in oncology, to unlock value and address persistent high short interest.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial (RILY) is trending following the filing of its Q3 report, bringing it into NASDAQ compliance and revealing strong financial performance that refutes previous concerns. The community is actively discussing the potential for a significant short squeeze, driven by high short interest and numerous in-the-money call options, believing the stock is poised for a substantial upward movement as the bearish thesis unravels.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

BMNR is trending intensely ahead of an imminent shareholder meeting featuring high-profile speakers Vitalik Buterin and Sam Altman. Community discussion is polarized around a critical vote on a massive share increase, with proponents anticipating strategic growth and increased Ethereum acquisition, while critics express significant concerns over potential dilution and its impact on shareholder value.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending amid reports that Sanofi is preparing a significantly improved takeover offer after the initial $16 per share bid was rejected by the board. The community is buzzing with expectations of a bidding war, with many anticipating a buyout price in the $20-$24 range, underscoring the perceived value of Ocular's assets, particularly ahead of crucial SOL-1 data.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following positive FDA feedback confirming existing trial data for sonelokimab is sufficient for a Biologics License Application (BLA) for hidradenitis suppurativa, significantly de-risking the asset. This regulatory clarity, combined with renewed speculation of a potential buyout from major pharmaceutical players, is fueling intense discussion, with many viewing a recent downgrade from a prominent investment bank as a contrarian buy signal. The community is actively discussing the drug's 'best-in-class' potential and anticipating substantial upside, advising investors to hold shares amidst perceived efforts to shake out retail investors.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares

The Direxion Daily Semiconductor Bull 3X Shares (SOXL) is surging, largely driven by robust earnings reports from key players like TSMC and Micron, reinforcing strong demand for AI chips. The community is buzzing with bullish sentiment, celebrating new highs and anticipating further upside, though some express caution about an "AI bubble" and the leveraged nature of the ETF. This has ignited discussions about the semiconductor sector's sustained growth trajectory versus potential overvaluation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$FARM Freddy&#39;s Frozen Custard &amp; Steakburgers was recently acquired by Rhône, a global private equity firm with offices in New York and London, in a deal reported at approximately $700 million in September 2025. The company was sold by Thompson Street Capital Partners, a St. Louis-based private equity firm that had owned Freddy&#39;s since 2021.  …. Deal done by northern mergers and acquisitions - same company advising farmer brothers

StockTwits for iOS

Farmer Bros. Co.

 Freddy's Frozen Custard & Steakburgers was recently acquired by Rhône, a global private equity firm with offices in New York and London, in a deal reported at approximately $700 million in September 2025. The company was sold by Thompson Street Capital Partners, a St. Louis-based private equity firm that had owned Freddy's since 2021.  …. Deal done by northern mergers and acquisitions - same company advising farmer brothers